Works by Redekop, W. Ken


Results: 31
    1
    2
    3

    Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.

    Published in:
    2016
    By:
    • Oemrawsingh, Rohit M.;
    • Akkerhuis, K. Martijn;
    • Van Vark, Laura C.;
    • Redekop, W. Ken;
    • Rudez, Goran;
    • Remme, Willem J.;
    • Bertrand, Michel E.;
    • Fox, Kim M.;
    • Ferrari, Roberto;
    • Jan Danser, A. H.;
    • de Maat, Moniek;
    • Simoons, Maarten L.;
    • Brugts, Jasper J.;
    • Boersma, Eric;
    • Danser, A H Jan;
    • PERGENE investigators
    Publication type:
    journal article
    4
    5
    6

    Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users.

    Published in:
    British Journal of Clinical Pharmacology, 2014, v. 78, n. 2, p. 422, doi. 10.1111/bcp.12346
    By:
    • Verhoef, Talitha I.;
    • Redekop, W. Ken;
    • Bouvy, Marcel L.;
    • Dorenbos, Brenda;
    • Karwar, Zamiera;
    • Schie, Rianne M. F.;
    • Boer, Anthonius;
    • Maitland‐van der Zee, Anke‐Hilse
    Publication type:
    Article
    7
    8
    9

    A conceptual disease model for adult Pompe disease.

    Published in:
    Orphanet Journal of Rare Diseases, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13023-015-0334-6
    By:
    • Kanters, Tim A.;
    • Redekop, W. Ken;
    • Rutten-Van Mölken, Maureen P. M. H.;
    • Kruijshaar, Michelle E.;
    • Güngör, Deniz;
    • van der Ploeg, Ans T.;
    • Hakkaart, Leona
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    19
    20
    21
    22
    23
    24
    27
    28
    29
    30
    31